Jefferies Downgrades Boston Scientific to Hold, Lowers Price Target to $46

Benzinga · 1d ago
Jefferies analyst Matthew Taylor downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $60 to $46.